Colonics
About Me
Recent Posts
- Congress Works On Tariff-Lowering Legislation For Haiti As Preval Meets With U.S. Leaders In Washington
- Cornyn And Boehner Sharpen Criticism Of Obama Health Proposal
- Medicine To Lower Blood Pressure Significantly Decreases Risk For Cardiovascular Disease, Stroke
- Study validates Chronix Biomedical’s serum DNA blood tests for early, accurate detection of breast cancer
- NYU Langone Medical Center Announces NYU Hospitals Center Receives Gold Seal Of Approval™ From The Joint Commission
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||
Friends
Links
Entry 1 of 1120
Last Page | Next Page
7/2/2009
-
Question marks on credibility of some published clinical trials
|
Randomised illegal drug Trials (RCTs) are calculated the 'gold standard' inquisition method for assessing new medical treatments. But quest published in BioMed Central's open access journal Trials shows that the design of a remarkable 93 percent of 2235 nominal RCTs published in some Chinese medical journals during 1994 to 2005 was flawed, casting doubt on the reliability of probing that is likely to pressure medical decision-makers. More: - Read More |
Post A Comment! :: Send to a Friend! |
Share and enjoy
